If youre looking for weight loss in the range of what GLP-1 medications produce, this isnt the right comparison
individuals with cardiovascular or renal disease)
Rather, they are a part of lifestyle modifications, and most people use these medications for cosmetic purposes
Furthermore, these studies have identified a threshold effect in male subjects, wherein fasting GLP-1 levels appeared to confer a protective effect against cancer risk [6]
The fundamental difference lies in retatrutide's broader receptor engagement approach, potentially offering enhanced metabolic benefits through simultaneous glucagon suppression and dual incretin hormone activation
Participants received apitegromab or placebo every 4 weeks for 24 weeks, followed by a 16-week safety period during which study treatments were not administered